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Abstract
Background: The king cobra (Ophiophagus hannah) is widely distributed throughout many parts of Asia. This study
aims to investigate the complexity of Malaysian Ophiophagus hannah (MOh) venom for a better understanding of king
cobra venom variation and its envenoming pathophysiology. The venom gland transcriptome was investigated using
the Illumina HiSeq™ platform, while the venom proteome was profiled by 1D-SDS-PAGE-nano-ESI-LCMS/MS.
Results: Transcriptomic results reveal high redundancy of toxin transcripts (3357.36 FPKM/transcript) despite small cluster
numbers, implying gene duplication and diversification within restricted protein families. Among the 23 toxin families
identified, three-finger toxins (3FTxs) and snake-venom metalloproteases (SVMPs) have the most diverse isoforms. These 2
toxin families are also the most abundantly transcribed, followed in descending order by phospholipases A2 (PLA2s),
cysteine-rich secretory proteins (CRISPs), Kunitz-type inhibitors (KUNs), and L-amino acid oxidases (LAAOs). Seventeen
toxin families exhibited low mRNA expression, including hyaluronidase, DPP-IV and 5’-nucleotidase that were not
previously reported in the venom-gland transcriptome of a Balinese O. hannah. On the other hand, the MOh
proteome includes 3FTxs, the most abundantly expressed proteins in the venom (43 % toxin sbundance). Within
this toxin family, there are 6 long-chain, 5 short-chain and 2 non-conventional 3FTx. Neurotoxins comprise the
major 3FTxs in the MOh venom, consistent with rapid neuromuscular paralysis reported in systemic envenoming.
The presence of toxic enzymes such as LAAOs, SVMPs and PLA2 would explain tissue inflammation and necrotising
destruction in local envenoming. Dissimilarities in the subtypes and sequences between the neurotoxins of MOh and
Naja kaouthia (monocled cobra) are in agreement with the poor cross-neutralization activity of N. kaouthia antivenom
used against MOh venom. Besides, the presence of cobra venom factor, nerve growth factors, phosphodiesterase,
5’-nucleotidase, and DPP-IV in the venom proteome suggests its probable hypotensive action in subduing prey.
Conclusion: This study reports the diversity and abundance of toxins in the venom of the Malaysian king cobra (MOh).
The results correlate with the pathophysiological actions of MOh venom, and dispute the use of Naja cobra antivenoms
to treat MOh envenomation. The findings also provide a deeper insight into venom variations due to geography, which
is crucial for the development of a useful pan-regional antivenom.
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Background
Toxin proteins appeared more than 200 million years
ago in the common ancestor of venomous reptiles such
as snakes and their saurian cousins [1]. The prevailing
thoughts on venom evolution agree that toxin genes
were initially recruited from genes of proteins with nor-
mal physiological functions, followed by repeated gene
duplication that creates redundancy, allowing a gene
copy to be selectively expressed in the venom gland. The
‘free’ copies subsequently underwent neofunctionaliza-
tion through positive selection and molecular adaptation
at accelerated rates, driven primarily by changes in the
ecological niche, diet and predator–prey arms race [2].
Besides gene duplications, alternative splicing and alter-
ations of domain sturctures are other mechanisms cap-
able of generating novel toxin genes [3]. The emergence
of paralogous groups of multigene families across taxo-
nomic lineages is accompanied by the occurrence of
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multiple isoforms within each major toxin family, resulting
in diverse functional variations of venom proteins that have
great impacts on medical management and toxinological
research [4]. The immerse variety of toxins also serves as a
source of leads for drug discovery. From a clinical stand-
point, the phenomenon gives rise to diverse snakebite syn-
dromes and potentially suboptimal antivenom effectiveness.
The phenomenon complicates snakebite management that
relies heavily on the understanding of venom complexity
and the availability of effective antivenom.
In most developing and under-developed countries, snake
envenomation remains a neglected tropical disease and a
disease of poverty [5]. Malaysia, as a tropical country that is
home to many venomous snake species, shares similar pub-
lic health concerns. The problem affects not only the rural
populations but also the suburban regions due to rapid
urbanization as the human populations increasingly en-
croach upon snake habitat [6–8]. Among the native snakes
in Malaysia, the king cobra (Ophiophagus hannah) is a
known cause of envenomation [6, 7], partly due to its popu-
larity among snake hobbyists. The king cobra is the world’s
largest venomous snake (over 3 m in length), capable of de-
livering huge amounts of venom per bite [9] (in our experi-
ence, > 1 g of dry venom mass per milking from this adult
king cobra). Clinically king cobra bites cause neurotoxicty,
paralysing respiratory muscles and leading to rapid death if
untreated. In surviving victims, the bites can result in ex-
tensive tissue necrosis and crippling deformity, adding to
the heavy toll of human suffering in socioeconomically de-
prived countries.
Ophiophagus hannah is widely distributed across the
Indian subcontinent, southeastern Asia and the southern
part of China [9]. As the generic name Ophiophagus
(Greek: Ophio-snakes, -phagous-eating) suggests, its diet
consists primarily of snakes, although small mammals are
also eaten. The Ophiophagus is a monotypic genus with
only one species recognized currently. However, its vast
geographical distribution accompanied by morphological
differences suggests potential taxonomic divergence and
variation in venom composition. In fact, the venom of
king cobra has been studied since the early 1970’s. Various
components have been isolated and characterized, includ-
ing L-amino acid oxidases [10], metalloproteinases [11],
three finger toxins (3FTxs) [12, 13], phospholipases A2
(PLA2s) [14, 15], ohanin [16], kunitz-type protease inhibi-
tors [17] and factor X activator [18]. Nonetheless, the sig-
nificance of the origin and intraspecific variation of king
cobra venom has only been recently documented. In a
study with venom samples sourced from a few countries,
differences in venom properties were noted between
Chinese and Southeast Asian king cobras [19]. A gen-
omic study of an Indonesian king cobra (a Balinese spe-
cimen) by Vonk et al. [20] indicated great diversity in
the PLA2 and 3FTx gene families in a single specimen.
Indeed, intraspecific variations of snake venom are at-
tributed to multiple factors such as diet, geographical
distribution, ontogeny, season/climate changes etc. [21],
and the phenomenon is hence highly relevant to the king
cobra in view of its extremely vast distribution. Producing
regional or local antivenom would be ideal; unfortunately
the production of an affordable and effective antivenom
tailored to different areas by local manufacturers would be
hampered by financial and technical constraints. Thus, a
new approach has been recently proposed by the toxinolo-
gical community to focus on the investigation of specific
venom-gland transcriptomes and venom proteomes for
the development of pan-regional antivenoms [22, 23].
Vonk et al. [20] reported the venom-gland transcriptome
and venom proteome of a specimen from the Indonesian
island of Bali. However, the possibility of intraspecific
venom variations from king cobra in the distant Malayan
Peninsula cannot be excluded. In addition, the paper re-
ported the numbers of toxin subtypes identified in the
venom proteome without the relative toxin abundances.
Earlier, Vejayan et al. [24] reported 2-dimensional gel elec-
trophoresis findings of the Malaysian king cobra venom
(commercial source, unspecified exact locality of the
snake). Unfortunately, their mass spectrometric analysis
(MALDI-TOF MS) yielded a large number of unidentifi-
able proteins, whilst only five toxin protein families were
determined (PLA2s, 3FTxs, serine protease inhibitors,
complement depleting factors, and ohanin) as well as one
non-toxin protein, thioredoxin. The study verified the pres-
ence of some previously isolated toxins but shed little light
on the venom proteome. Another recent report on king
cobra(s) venom of probable Thai origin profiled the venom
as well, detecting 14 protein types/families (including hypo-
thetical proteins), but again without the estimation of rela-
tive toxin abundance [25]. The 1D electrophoretic gel
findings of the Thai king cobra venom appeared similar to
that reported by Chang et al. [19], suggesting that 3FTxs
are the major component of king cobra venoms of different
localities. However, the diversity in toxin sequences and
isoforms as well as variations in toxin abundance could
not be ascertained. To remedy the current lack of venom-
gland transcriptomic and venom proteomic data for the
Malaysian king cobra, the current study employed next-
generation sequencing technology (massively parallel se-
quencing) and nano-liquid chromatography-tandem mass
spectrometry (nano-LCMS/MS) for a deeper insight into
the toxin diversity of king cobra venom.
Results
Sequencing and transcriptome assembly
From the primary output statistics of transcript sequen-
cing, a total of 52,280,572 pairs of clean reads passed the
Illumina quality filter for further de novo assembly using
the short reads assembling program, Trinity [26]. Trinity
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created 164,775 Contigs (N50 = 459), connected to form
78,882 Unigenes (N50 = 864) in total as shown in Fig. 1.
BLASTx alignment (e-value < 0.00001) between the Uni-
genes and sequences in the NCBI non-redundant (nr) pro-
tein database yielded 36,753 annotated Unigenes (Additional
file 1). After filtering low-frequency transcripts (less than 1
FPKM, Fragments Per Kilobase of exon model per Million
mapped reads), the assemblies were reduced from 78,882 to
68,472 transcripts and categorized into unidentified (39,888
transcripts), non-toxin (28,456) and toxin (128) groups. Of
these, 20 toxin transcripts encode full-length toxin se-
quences. Although the toxin group accounted for 128 tran-
scripts only, it is abundantly expressed as much as 35.3 % of
the total expression (based on the parameter FPKM),
whereas the unidentified and non-toxin groups were 20.8 %
and 44.9 % respectively (Fig. 2). Toxin transcripts were
expressed at extremely higher redundancies (3357.36
FPKM/transcript) compared to non-toxin transcripts
(18.81 FPKM/transcript) (Additional file 1).
Venom-gland transcriptome
The identifiable toxin transcripts (128 partial and complete
transcripts, 35.3 % of the total FPKM) represent 23 protein
families related to venom toxic functions. The toxin con-
stituents, as indicated by FPKM, are dominated by 3FTxs
(84.9 %). The toxin transcript abundances are followed by
snake venom metalloproteases (SVMPs, 3.7 %), phospholi-
pases A2 (PLA2s, 2.2 %), cysteine-rich secretory proteins
(CRISPs, 2.1 %), Kunitz-type proteinase inhibitors (KUNs,
1.8 %) and L-amino acid oxidases (LAAOs, 1.5 %). A
variety of toxin or protein mRNAs is expressed in low
abundances (<1 %), including cobra venom factors (CVFs),
vespryn, natriuretic peptides (NPs), snake venom serine
proteases (SVSPs), phosphodiesterases (PDEs), nerve
growth factors (NGFs), acetylcholinesterases (AChEs),
neprilysins, hyaluronidase, phopholipases B (PLB), cysta-
tins, dipeptidylpeptidase IV (DPP-IV), 5’nucleotidases
(5’NUCs), waprins, C-type lectins (CTLs), insulin-like
growth factors (IGFs), and vascular endothelial growth
factors (VEGFs) (Fig. 2). The sequences and parameter de-
tails of the transcripts were sorted according to gene fam-
ilies and compiled in Additional file 2.
Venom Proteome
When examined under reducing 15 % SDS-PAGE, MOh
venom showed three major protein bands each with a dis-
tinct molecular mass range: high (50-70 kDa), intermedi-
ate (20-30 kDa), and low (<14 kDa). The gel as shown in
Fig. 3 was divided into 12 sections of equal sizes in prepar-
ation for in-gel digestion and nano-LCMS/MS, and the
protein abundances from each section were estimated by
gel densitometry for in-gel protein amount correlation
[27]. Proteins were detected by nano-LCMS/MS from all
gel sections including the pale-staining ones (Sections 1,
2, 5, 6, 8 and 9) notwithstanding their low abundances.
The MOh venom proteins mainly migrated to Section 3,
4, 7, 10, 11 and 12, accounting for approximately 90 %
(21.7 %, 8.3 %, 7.5 %, 7.9 %, 43.0 % and 3.2 %, respectively)
of the total venom protein (Additional file 3).
A customized reference database (NCBI Serpentes
merged with MOh venom-gland transcriptome) was used
in data mining to identify peptides sequenced by tandem
mass spectrometry. A total of 45 toxins were identified
from the MOh venom; 20 of these were matched to the
transcripts. All toxins were assigned to 16 protein families.
3FTxs and SVMPs were the most abundantly expressed
toxins in the proteome, accounting for 43.0 % and 24.4 %,
respectively, of the venom. This was followed by CRISP
(8.7 %), LAAOs (5.7 %), vespryn (5.7 %), PLA2 (4.0 %) and
CVFs (2.8 %). Protein families with an abundance of less
than 2 % each were categorized into “others” and consid-
ered as low-abundance proteins (a total of 9 protein
families) (Fig. 4). The sequences and parameter details of
the proteins identified were sorted according to gel sec-
tions and protein families as compiled in Additional file 3.
Fig. 1 De novo transcriptome assembly with short reads assembling program, Trinity. a Length distribution of Contigs from reads assembly.
b Length distribution of Unigenes generated from connected Contigs
Tan et al. BMC Genomics  (2015) 16:687 Page 3 of 21
Based on the proteomic data, transcript sequences of
translated major toxins were selected for sequence com-
parison with related toxins. The sequence alignments of the
major transcripts were illustrated in the following figures
according to their respective toxin families: 3FTxs (Fig. 5),
SVMPs (Fig. 7), CRISPs (Fig. 8), LAAOs (Fig. 9), vespryns
(Fig. 10), PLA2s (Fig. 11) and CVFs (Fig. 12). Figure 6 shows
the phylogenetic tree of the major 3FTxs of MOh.
Comparison between transcriptome and proteome
In this study, data from the venom-gland transcriptome
(FPKM metrics) and the venom proteome (cumulative
Fig. 2 The Malaysian Ophiophagus hannah venom gland mRNA expression profile. Pie charts mainly display the percentage abundance of toxin
transcripts. Toxins transcripts accounted for 35.3 % of the total FPKM. Three-finger toxins are the most abundant toxin family in the venom gland
(84.9 % of all toxin transcripts). 3FTx, three-finger toxin; SVMP, snake venom metalloproteinase; PLA2, phospholipase A2; CRISP, cysteine-rich
secretory protein; KUN, Kunitz-type proteinase inhibitor; LAAO, L-amino acid oxidase; CVF, Cobra venom factor; IGF, insulin-like growth factor; NP,
natriuretic peptide; SVSP, snake venom serine protease; PDE, phosphodiesterase; NGF, nerve growth factor; AChE, acetylcholinesterase; PLB,
phospholipase-B; DPP IV, dipeptidylpeptidase IV; CTL, C-type lectin; VEGF, vascular endothelial growth factor
Fig. 3 Densitometry quantitative measurement of SDS-PAGE gel using myImageAnalysis Software. a SDS-PAGE gel sections cutting scale with
protein marker range from ~10kDa to 170kDa. b Gel densitometry section 1 to 12 displayed in percentages (%)
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of peptide fragment ratio per unit length) derived from
the same specimen did not show significant correlation
(FPKM v.s. PPUL metrics: r2 = 0.013, p > 0.05).
Table 1 summarized the quantitative results of the tran-
scripts and proteins by toxin family for the Malaysian king
cobra studied. In addition, the “–omic” information avail-
able for the Balinese king cobra [20] was included along in
Table 1 for comparison purposes. Of note, the transcripts
by protein family for the Balinese specimen were denoted
as present or absent as quantitative data on transcript
abundances were not available [20]. In addition, the ex-
pression of the percentage of toxin family in the venom
proteome is different between the two studies: this current
study (on Malaysian king cobra) reports the relative abun-
dance of protein in each toxin family (in addition to the
number of protein subtypes); whereas the other (on
Balinese king cobra) [20] indicated the relative number of
toxin subtypes without estimation of protein abundance.
Sequences of toxin transcripts of the two king cobras were
compared and compiled in Additional file 4.
Discussion
Venom-gland transcriptome
High redundancy was observed overall in the toxin genes,
indicating that multiple toxin isoforms are highly expressed
in the venom gland in contrast to non-toxin genes. The
phenomenon supports the hypothesis that the toxins were
products of repeated gene duplications which underwent
molecular adaptation for subsequent neofunctionalization:
the evolutionary mechanism proposed to be behind the as-
tonishing molecular diversity of snake venoms [4]. Sixty
three of the 128 toxin transcripts show high homology with
sequences previously reported for Ophiophagus hannah,
while the other sequences (> 50 %) are at variable degrees
of similarity to toxins from other taxa, consistent with the
view that toxin genes expanded from a limited pool of pro-
tein families among the advanced snakes [2, 4].
The MOh venom-gland transcriptome reflects the use
of venom as an innovated predatory strategy. The role of
3FTxs as the principal toxins in MOh venom is supported
by the fact that they are the most abundantly expressed
and the most isomerically diverse toxin genes. The 3FTx
mRNA expression level in our study appears to be higher
(85 %) than that reported by Vonk et al. [20] in a Balinese
specimen (about 65 % but unspecified) (Table 1). A total
of 18 unique 3FTx transcripts are identified and classified
as short-chain (5), long-chain (3) and weak (7) neurotoxin
isoforms, as well as neurotoxin-like hypothetical proteins
(3) (Fig. 5a). In king cobra envenomation, the neurotoxins
are thought to be the major pathogenic cause of rapid
death mediated through neuromuscular paralysis and re-
spiratory failure, attributable to the curare-like neuro-
toxins of the 3FTx family [28, 29]. From the venom-gland
trasncriptome, high expression levels were also noted for
the genes of SVMPs and PLA2s (2-4 % of total toxin
transcripts). SVMPs and PLA2 are two enzymes com-
monly present in snake venoms across the Elapidae and
Viperidae [21]. The SVMP genes of MOh appear highly
diverse (18 transcripts); the multiple isoforms are suggest-
ive of the vast biological activities of the enzyme. The
PLA2 transcripts, on the other hand, are comprised of
only 2 distinct sequences, representing a finding of low se-
quence diversification similar to that in LAAOs (3 distinct
transcripts). The enzymatic products of these genes are
not usually involved directly in lethality but play ancillary
roles in causing tissue inflammation and destruction
(further details are discussed below). Meanwhile, approxi-
mately 65 % of the non-toxin genes appear unrelated to
envenomation. Most of these are housekeeping genes asso-
ciated with cellular metabolisms, and they are transcribed
at very low FPKM levels, marked with low redundancies.
Fig. 4 Protein expression profiles of Malaysian O. hannah venom with a total of 116 unique toxins peptides identified encoded for 16 protein families.
Three-finger toxins are the most abundant toxin family in the MOh venom (44.01 %). 3FTx, three-finger toxin; LAAO, L-amino acid oxidase; SVMP, snake
venom metalloproteinase; CRISP, cysteine-rich secretory protein; CVF, cobra venom factor; PLA2, phospholipase A2; 5’NUC, 5’nucleotidase; KUN, Kunitz-
type protease inhibitor; SVSP, snake venom serine protease; PDE, phosphodiesterase; NGF, nerve growth factor; PLB, phospholipase-B;
AChE, acetylcholinesterase
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Venom proteome
When used in combination, the next generation transcrip-
tomic and proteomic analyses can provide a powerful ap-
proach to unveil the molecular complexity of venom
toxins. This approach was adopted in the current study
for a better correlation of the two processes of gene ex-
pression and protein synthesis in the venom glands of the
Malaysian king cobra. Among the many proteomic
methods, we employed a sequential method of 1D-SDS-
PAGE followed by in-gel digestion and nano-ESI-LCMS/
MS. A simpler method of whole venom in-solution
LCMS/MS is time-saving, cost-friendly, and has been
tested out in several venomic studies [20, 30, 31]; however,
additional steps of venom protein separation such as SDS-
PAGE prior to LCMS/MS are known to be effective to
“de-complex” the venom and thus greatly enhance the
protein identification by LCMS/MS [32].
In this study, the 1D-SDS-PAGE pattern of MOh venom
is similar to the observation reported in Chang et al. [19].
The authors deduced that the prominent bands of king
Fig. 5 Sequence alignments of three-finger toxin (3FTx) transcripts of Malaysian O. hannah venom-gland transcriptome. a Malaysian O. hannah
3FTxs were aligned to show disulfide bonding (Black line: disulfide bond loops; Blue: additional disulfide bond of S-3FTxs; Red line: additional
disulfide bond of L-3FTxs). b L-3FTxs were aligned and compared to sequences from Balinese king cobra [20] and public database (Green line:
critical residues of L-3FTxs; Blue: identical residues to WNTX-33). c S-3FTxs were aligned and compared to sequences from Balinese king cobra
[20] and and public database (Green: critical residues of S-3FTx)
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cobra venoms were represented by LAAOs and SVMPs
(53-65 kDa), CRISPs (27 kDa), PLA2s and 3FTxs (<14
kDa), without reporting their relative abundances. Our
approach in examining the protein composition through-
out the electrophoretic passage has made it possible to es-
timate the relative abundance of these toxins, in addition
to the detection of several other proteins. While the gen-
omic disclosure by Vonk et al. [20] has been an excellent
reference for the evolution and toxin diversity of the Bali-
nese king cobra venom, the individual toxin abundance has
not been reported. Our current study that revealed the
relative abundance of toxins in MOh venom is thus hoped
to provide further insights and correlation between the tis-
sue transcriptome and toxin expression profiles in king
cobra. It is however worth noting that toxin variations can
still exist between venoms of different geographical origins.
It is interesting to note that 3FTxs and PLA2 in MOh
venom made up approximately 47 % of the overall abun-
dance, apparently less than in the venoms of local elapids
such as Naja cobras and kraits, where the total abundance
of these two major toxins can be as high as 70-80 % [33, 34].
Instead, a substantial amount of SVMPs (> 20 %), CRISP
(> 5 %) and LAAOs (> 5 %) were found expressed in the
MOh venom. A hypothesis for the difference could be
that the non-neurotoxin components act synergistic-
ally in MOh venom in order to subdue neurotoxic elapids
such as cobras, which are known to be resistant to neuro-
toxins [35].
Comparison of transcriptome and proteome
The expression of mRNAs and protein abundance are not
necessarily identical due to various cellular regulatory
processes e.g., post-transcriptional, translational and protein
degradation that control the steady-state protein abun-
dances [36]. Moreover, the correlation between transcrip-
tomic and proteomic abundances in snake venom has
traditionally been poor [37]. It should be noted that in the
correlation study, the protein expression is ideally measured
based on peptide unit, analogous to the analysis for RNA
expression described by Mortazavi et al. [38] in order to
correct for the molecule size of messenger transcript and
protein. Using this approach, Aird et al. [31] reported a sig-
nificant correlation of the data (from transcriptome and
proteome) for two East Asiatic crotalids, although some
variances in the results remained unexplained possibly due
to biological as well as analytical factors [31]. Our study on
the MOh specimen, however, showed no significant correl-
ation between the venom-gland transciptome and the
venom proteome. The correlation may be influenced by
many factors, one of which is the time span between venom
collection and gland tissue harvesting. In this study, the
venom glands had been stimulated by venom milking sev-
eral days prior to their harvesting as a step to maximise the
mRNA synthesis. Admittedly, toxin components can be
synthesized at different rates and hence the respective met-
rics of mRNA and protein expressions taken at one particu-
lar time point may not be well correlated. In addition,
Fig. 6 Phylogenetic tree of selected 3FTx transcripts of Malaysian O. hannah constructed with MEGA 6 using the Maximum likelihood method
and presented by FigTree 1.4. (UniprotKB accession numbers of proteins used to construct the tree are as follows: Q53B59: Long neurotoxin OH-37,
Q53B57: Long neurotoxin OH-56, Q53B58: Long neurotoxin OH-55, Q2VBP8: Long neurotoxin LNTX1, S6CB76: Three-finger toxin, P01391:
Alpha-elapitoxin-Nk2a, A1IVR8: Alpha-elapitoxin-Bc2a, Q9W717: Neurotoxin-like protein NTL2, P84716: Neurotoxin-like protein 1, P82849:
Cobrotoxin II, P14613: Short neurotoxin 1, P60775: Erabutoxin a, P01479: Neurotoxin-1). Neurotoxin-1 Androctonus australis used as outgroup
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extensive post-translational modifications occur in many
complex toxins such as SVMPs; hence the mature proteins
produced may not be necessarily congruent to the mRNA
expressed. These factors may explain some of the variances
in the data presented here and elsewhere [31, 37]. In the
following section, we further discuss the expression of
MOh toxins according to their protein families.
Major transcripts and venom constituents
Three-finger toxins (3FTxs)
Three-finger toxins (3FTxs) comprise a family of non-
enzymatic polypeptides of 60-74 amino acid residues with
four or five disulfide bridges [39]. 3FTxs are usually the
principal toxins found in the venoms of elapid snakes such
as king cobra, Naja cobras, coral snakes, kraits, mambas
and sea snakes [21, 40, 41]. The genes may have been
recruited before the divergence of different venomous
snakes, as low levels of 3FTx transcripts have been re-
ported in the venom-gland transcriptomes of some viper-
ids and colubrids [31, 42–44]. The classification of 3FTxs
in general is made based on the number and position of di-
sulfide bonds. Short-chain 3FTxs (S-3FTxs) possess only
four disulfide bonds, while long-chain 3FTxs (L-3FTxs)
have five with an additional disulfide bond at the distal
Table 1 Comparison of the venom-gland transcriptomes and the venom proteomes of king cobra (Ophiophagus hannah, Oh) from
Malaysia (Seremban) and Indonesia (Bali)
Venom-gland transcriptome Venom Proteome
Malaysian Oh (Current study) Balinese Oh (Vonk et al., 2013) Malaysian Oh (Current study) Balinese Oh (Vonk et al., 2013)
Toxin Family aTranscript (abundance in %) bTranscript detected cRelative abundance of toxin
in % (number of subtype)
dRelative presence of toxin
in % (number of subtype)
3FTXs 84.95 √ 43.0 (13) 41.1 (30)
SVMP 3.68 √ 24.4 (12) 24.7 (18)
PLA2 2.16 √ 4.0 (1) 5.5 (4)
CRISP 2.12 √ 8.7 (1) 6.8 (5)
KUNs 1.84 √ 1.0 (1) 4.1 (3)
LAAO 1.47 √ 5.7 (2) 1.4 (1)
CVF 0.63 √ 2.8 (4) 5.5 (4)
Vespryn 0.58 √ 5.7 (1) 1.4 (1)
IGF 0.52 √ - -
NP 0.48 √ - 1.4 (1)
SVSP 0.47 √ 0.7 (1) 4.1 (3)
Cystatin 0.25 √ 0.7 (1) -
PDE 0.22 √ 1.1 (2) 1.4 (1)
NGF 0.20 √ 0.8 (1) -
AChE 0.14 √ 0.1 (1) -
Neprilysin 0.11 √ 0.7 (2) -
Hyaluronidase 0.07 - - -
PLB 0.07 √ 0.2 (1) -
Waprin 0.06 √ - -
DPP IV 0.02 - - -
5' Nucleotidase 0.02 - 0.4 (1) -
CTL 0.01 √ - -
VEGF 0.01 √ - 2.7 (2)
Total 100 100.0 (45) 100.0 (73)
aThe relative abundance of a particular transcript was expressed in percentage of total FPKM of all toxins. Values shown are percentages sorted according to toxin
gene families
bThe detection of transcript sorted according to toxin gene family. Exact quantitative values were not provided in the original report. √ indicates detection
cThe relative abundance of a particular toxin was expressed in percentage of total mean spectral intensities of all toxins (adjusted to gel intensity). Values shown
are percentages sorted according to toxin protein families. The numbers of subtype within each family are indicated in brackets
dThe relative ‘presence’ of a particular toxin was expressed in percentage of the total number of all toxin subtypes (n = 73). Values shown are percentages sorted
according to toxin protein families. The numbers of subtype within each family are indicated in brackets
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end of loop II. “Non-conventional 3FTxs” (NC-3FTxs) also
have five disulfide bonds, with the fifth bond located
within loop I of the molecule [28] (Fig. 5a).
The molecular diversity of 3FTx genes of MOh is well
reflected by the presence of multiple unique 3FTx tran-
scripts. The two main 3FTxs of MOh, MOh_FTX01 and
MOh_FTX02, share sequence consensus to most curare-
like α-neurotoxins as shown in Fig. 5b. MOh_FTX03 is
similar to an uncharacterized 3FTxs (S6CB76) in the data-
base with an unknown mechanism of action. L-3FTxs
constitute the majority of 3FTx transcripts in the venom
gland, notably MOh_FTX01 (74.04 %) (Additional file 2).
Interestingly, MOh_FTX01, a long-chain neurotoxin, has
an N-terminal peptide sequence (21 terminal amino acids)
not seen in other L-3FTxs but identical to that of a weak
neurotoxin, WNTX-33 (Fig. 5b). The sequence in the cen-
tral core of MOh_FTX01 is nevertheless similar to most
other long-chain neurotoxins. It is known that the func-
tional sites of long-chain neurotoxins e.g., α-cobrotoxin/
elapitoxin from Naja kaouthia reside mainly in the second
loop of the toxin, with important residues of K23, D27,
R33 and K49, while the first loop is not involved in the
toxin function [45]. MOh_FTX02 and MOh_FTX03 were
found to contain all the critical residues except that the
major L-3FTxs, MOh_FTX01 showed substitution of K23
with glutamine and K49 with asparagine. The effect of
variations on these critical residues were unknown.
Among the S-3FTx transcripts identified, the three most
abundantly expressed isoforms (MOh_FTX06, MOh_
FTX07 and MOh_FTX09) are homologous to neurotoxin-
like protein 1, hypothetical protein L345_15308 (which was
also similar to neurotoxin-like protein NTL2) and muscar-
inic toxin-like protein 3 homolog, respectively (Fig. 5c).
These transcripts belong to the 3FTx “orphan group”
(atypical 3FTxs); with the exception of the muscarinic
toxin-like protein, the functions of the other two
neurotoxin-like proteins are not well understood [46]. A
similar type of transcript has also been reported in Bali-
nese O. hannah [20], suggesting that some atypical 3FTxs
are conserved . Site-directed mutagenesis and nicotinic
cholinergic receptor (nAChR) binding studies using the
short-chain α-neurotoxin, Erabutoxin a (from the sea krait
Laticauda semifasciata), revealed that the functional sites
of the molecule are distributed over the tips of all three
loops in the toxin, including S8 and Q10 in loop I and
K27, W29, D31 and R33 that play important roles in
short-chain neurotoxin selectivity and affinity to nAChR
[47, 48]. In contrast, the functional site of L-3FTxs lies
mostly within the second loop of the toxin. The lack of
the critical resides Q10 in MOh_FTX06; Q10 and W29 in
MOh_FTX07; Q10 and K27 in MOh_FTX09 (Fig. 5c) im-
plies their potential structural-function differences in the
MOh venom. Although they are categorized as S-3FTxs
(carrying 4 disulfide bonds), the unusual N-terminal
amino acid sequences presented in these transcripts may
influence the toxin-receptor binding as the tip of the first
loop of the typical short-chain neurotoxin, Ea has been
shown critical for its binding with the receptor [48]. Three
other S-3FTx transcripts encode a typical short-chain
neurotoxin SNTX11 (MOh_FTX08), a Type A muscarinic
toxin (MOh_FTX010) and a cytotoxin, cardiotoxin-3
(MOh_FTX11), all at extremely low expression levels (0.01-
0.03 % of toxin FPKM). Their roles in envenomation have
not been elucidated through functional studies.
On phylogenetic analysis, S-3FTx, L-3FTx and NC-
3FTx were grouped into separate clusters on the phylo-
genetic tree (Fig. 6). Genes for both the S-3FTxs identified
in MOh venom proteome are basal in the phylogenetic re-
lationship. The finding supports that 3FTx genes of MOh
evolved from short-chain isoforms which later adapted
and diverged into genes encoding non-conventional 3FTxs
and long-chain 3FTxs. The phylogenetic analysis also
showed that the main L-3FTx, MOh_FTX01 is more
related to the long-chain neurotoxin OH55/56 of the
Balinese specimen [20], but distantly diverged from α-
cobrotoxin/elapitoxin, indicating their distinctness from
the long-chain neurotoxins of Naja cobra (Fig. 6).
On the venom proteome, the number of expressed MOh
3FTxs in this study (n = 13) is less than that reported for
the Balinese specimen (n = 31, whole-venom shotgun
analysis) [20] (Table 1). It is however comparable to the
number of 3FTxs reported for the Thai specimen (n = 16,
1DE-shotgun method) [25] and is more diverse than that of
the other two Malaysian king cobra samples studied using
chromatography separation (n = 7) [19] and 2DE method
(n = 7) [24]. The discrepancies could be due to the use of
the sensitive nano-LCMS/MS in our study, or geographical
variations of the venom within Malaysia (exact locality of
the snake is unknown in [19] and [24]). The current study
further showed that the L-3FTxs and S-3FTxs account for
62.1 % and 28.8 % of total 3FTx abundance in the prote-
ome, while the non-conventional 3FTxs constitute the least
(< 3 % of total 3FTxs) (Additional file 3). In term of all pro-
tein abundance, the amount of 3FTxs in MOh venom is
hence 43.0 %, a finding comparable to Chang et al. [19]
(44.1 % w/w), although the 3FTx subtypes varied between
these two studies. While Chang et al. [19] concluded that
S-3FTxs constituted 41 % w/w of their Malaysian venom
sample with L-3FTxs constituting only 3 % w/w, we dem-
onstrated a lesser extreme distribution of S-3FTx:L-3FTx
with a ratio of 1:2 (in relative abundance). The major form
of L-3FTx by toxin abundance is nonetheless same in both
studies, viz. OH55 (a lethal long neurotoxin, hannalgesin,
and a homolog to MOh_FTX01 transcript). Similarly, the
3FTxs in our MOh venom appear to be primarily neuro-
toxins of variable isoforms, with a very minimum content
of cytotoxin or cardiotoxin (0.5 % of total abundance), a
finding comparable to Chang et al. [19] (0.4 % cytotoxin).
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Interestingly, muscarinic toxin-like proteins (S-3FTx sub-
type) and several NC-3FTxs were expressed in MOh
venom at trace amounts; these isoforms have not been re-
ported in the previous studies of Malaysian specimens [19].
The cytotoxin and non-conventional 3FTxs of low abun-
dance in MOh venom likely play minimal role in the lethal
action of the venom in view of their minute amount and
the higher LD50 value (indicating lower toxicity) compared
to alpha-neurotoxins [41]. The proteomic presence of long
neurotoxin OH56 in the MOh venom also contrasts with
the previous conclusion [19] which proposed this to be one
of the unique 3FTx markers exclusive for Chinese king
cobra (of Guangxi and Hainan origins) and not supposed
to be present in the Southeast Asian specimens. Our find-
ing hence indicates that the 3FTx profile of king cobra may
be more complex and diverse than previously thought.
Nonetheless, the presence of a large number of 3FTx vari-
ants in high abundance also implies the possibilities of vari-
able protein structure folding, toxin-receptor interaction
and potency. In addition, the immunogenicity of the venom
is likely determined by the abundant 3FTxs; the small
molecular sizes and diverse epitopes of 3FTxs can be a
challenge to the production of a high efficacy antivenom.
Using a computerized model to analyse long NTX se-
quences retrieved from UniProtKB database, Danpaiboon
et al. [25] predicted that a total of 7 amino acids in a king
cobra long NTX (Q2VBP4, Chinese origin) interacted
with the human single-chain variable antibody fragments
specific to N. kaouthia long NTX (NkLN-HuScFv) at the
following 7 amino acids: C26, W29, G31, R33, K36 in loop
2, and R47, N49 in loop 3, hence supporting the appar-
ently weak cross-neutralization effect of NkLN-HuScFv
against the lethal effect of king cobra (Thailand) in mice.
However, matching of the said interactive amino acids
of Q2VBP4 to the major NTXs (abundance > 10 %) in
MOh venom (OH55, OH56, LNTX2, MOH_FTX07 and
neurotoxin-like protein 1) yielded limited similarity (10-40
% matching). This suggests that NkLN-HuScFv may not
be effective in neutralising the king cobra venom from
Malaysia. From the practical standpoint, Leong et al. [49]
confirmed in a mouse model that Thai Naja kaouthia
monovalent antivenom (NKMAV) has low neutralization
capacity against MOh venom, indicating the antigenic dis-
similarities of both venoms despite the conserved protein
scaffolds between neurotoxins of MOh and N. kaouthia.
This is not surprising considering the fact that the anti-
venom manufacturer has to combine venom immunogens
from both king cobra and N. kaouthia (in addition to two
Bungarus species) in order to produce the effective Neuro
Polyvalent Antivenom (NPAV). Clinically, an attempt to
treat Malaysian O. hannah envenomation in Kuantan,
Malaysia with NKMAV has proven in vain as the
antivenom against N. kaouthia failed to cross-neutralize
both the systemic and local effects from the bite [50]. In
the MOh envenoming case, the systemic effects were only
arrested much later with the arrival and administration of
the king cobra-specific antivenom.
We postulate that the neurotoxins of MOh are highly
distinct to those of Naja cobras’ as a result of adaptive evo-
lution and positive selection to ensure that the MOh neu-
rotoxins are sufficiently effective to bind Naja’s nicotinic
receptor since Naja cobra is a prey top in king cobra’s food
list – a known predator–prey phenomenon in palm oil
estates in Malaysia. Generally, Naja cobra is resistant to
NTX as their receptors have been mutated with a sugar
chain that masks the binding by NTX [35]. In addition to
distinct neurotoxins, the MOh venom proteome also re-
veals abundant high molecular mass proteins (mainly en-
zymes) not commonly present in large amount in Naja
cobra venoms, implying their potential roles in killing and
digestion of other neurotoxic snakes by king cobra. The
higher share of non-3FTx components (e.g., CRISP, SVMPs,
LAAOs, vespryn; generally have lower lethality) in the
MOh venom may be a reason for the venom’s higher LD50
(> 1 μg/g, i.v.) in mice compared to that of Naja venom
(for instance, 0.2 μg/g for Thai N. kaouthia) that is predom-
inated with alpha-neurotoxins [40, 49]. This is supported
by an earlier report [51] where the major neurotoxic frac-
tion of MOh venom, purified by ion-exchange chromatog-
raphy and accounted for ~23 % venom weight, has an i.v.
LD50 of 0.23 μg/g mice, a value disproportionally lower
than that of the crude venom (> 1 μg/g).
Snake venom metalloproteinases (SVMPs)
From the MOh venom-gland transcriptome, the
SVMP transcripts encode at least 15 unique SVMPs,
with sequence similarities matched to SVMP-ohanin,
SVMP-cobrin, SVMP-BmMP, SVMP-kaouthiagin, SVMP-
mocarhagin-1, SVMP-atrase-A, Chain-A-SVMP, asrin
and carinatease-1 from different elapid snakes (Fig. 7;
Fig. 7 Sequence alignments of snake venom metalloproteinase (SVMP) transcripts of Malaysian O. hannah venom-gland transcriptome in comparison
with SVMP sequences of representative venomous snakes. (Black: metalloproteinase domain; Red: disintegrins domain; Blue: cysteine-rich domain;
Green: XXCD region)
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Additional file 4). The sequence divergence is evident,
supporting the view of extensive diversification of SVMP
functions under accelerated evolution [11]. All the
identified SVMP transcripts belong to the P-III class (with
metalloproteinase/ disintegrin/ cysteine-rich (MDC) do-
mains), the SVMP type that has a rich array of biological
activities, including potent haemorrhagic activity, inflam-
mation, apoptosis, prothrombin activation, and inhibition
of platelet aggregation [52]. From the SVMP transcript se-
quences of MOh, we identified the absence of the seventh
cysteine residue in Domain M that takes part in the
disulfide bond exchange for autolysis during secretion or
formation of the biologically active DC domain, typical for
Viperidae SVMP-PIIIs [52, 53]. Figure 7 shows that the
MOh and annotated SVMP-PIII (except asrin A6XJS7) M
domains from several elapids have only six cysteine resi-
dues, consistent with previous studies [52] including that
for Balinese king cobra [20]. The effect of structural differ-
ence as such has been shown by Guan et al. [54] that no
autolytic activity was observed during the preparations of
two P-III SVMPs sourced from the Taiwanese Naja atra.
Thus, the SVMP-PIIIs of Malaysian O. hannah and most
elapids likely exhibit the similar structure-function proper-
ties distinct from those of viperids.
Some proteomic studies indicated that SVMPs are
expressed mainly in the Viperidae and Colubridae
venoms, and in a relatively smaller amount in Elapidae
venoms [53]. Our findings revealed that SVMPs are
present in a substantial amount in the MOh venom, with
a total of 12 proteins detected. Our finding of diverse and
abundant SVMPs in MOh venom is in agreement with
Vonk et al. [20] on the view that SVMPs are important
pathogenic toxins besides 3FTXs in the Balinese king
cobra venom. This is also supported by Chang et al. [19]
who reported high metalloproteolytic enzyme activity in
king cobra venoms, although the authors did not deter-
mine the subtypes and composition of SVMPs in the
venoms. On the other hand, SVMP was not identified at
all in the previous 2DE proteomic study of Malaysian king
cobra [24], a rather peculiar finding that raises a conflict
in local venom database, possibly due to inadequacy of the
methodology. Earlier studies indicated that at least five
SVMP isoforms with proinflammatory and oedema-
inducing activities were present in king cobra venoms,
two of which were proven to be hemorrhagic proteases
[55]. The major hemorrhagic protease, termed hannah-
toxin, is a 66-kDa zinc-dependent metalloprotease that ex-
hibited species-specific lethality, where it is highly lethal
to rabbit but not to mice at comparable doses [56, 57]. Al-
though local hemorrhage is not a well-recognized clinical
feature of king cobra envenoming, the proteolytic and
proinflammatory activities of SVMP may be involved in
cytotoxicity leading to necrosis and tissue destruction.
Cysteine-rich secretory proteins (CRISPs)
Multiple sequence alignment [Fig. 8] of the 7 CRISP tran-
scripts shows that the sequences are highly conserved
across different snake species and the complete sequence
of MOh_CRP03 obtained is almost identical to ophanin se-
quence derived from UniprotKB database, including its
functional region known for the inhibition of smooth
muscle contraction [58]. This is in agreement with the
transcriptomic finding reported for the Balinese king cobra,
where CRISP is found with limited diversity and little evi-
dence of gene duplication [20]. This gene family likely has
conserved functional activities across most lineages, and
does not participate in the evolutionary arms race seen in
the more pathogenic toxin families such as 3FTx.
The presence of CRISPs in king cobra venom proteome
varies between studies. CRISP is not reported in two previ-
ous studies on the venom proteome of Malaysian king
cobra [19, 24]. In the present study on MOh venom, one
CRISP isoform was identified, consistent with the finding
from the Thai specimen [25] but varied from the Balinese
which recorded a total of 5 CRISP isoforms [20]. In MOh
venom, opharin precusor is the identified CRISP isoform.
This toxin has the putative function of reducing smooth
muscle contraction that is elicited by high potassium-
induced depolarization. The degree of inhibition by opharin
is however lower than most other CRISPs [58], possibly
due to the critical amino acid difference essential for chan-
nel activity inhibition: as with ophanin, the translated MOh
CRISP possesses Y189 in substitution of F189 (present in
strong contractors) and Y186 instead of E186 (present in
Fig. 8 Sequence alignments of cysteine-rich secretory protein (CRISP) transcripts of Malaysian O. hannah venom-gland transcriptome in comparison
with CRISP sequences of representative venomous snakes. (Black lines differentiate PR-1 domain/Hinge region/Cysteine-rich domain; Red:
Functional region)
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most blockers of smooth muscle contraction) (Fig. 8).
Although the pharmacological activity of ophanin as a weak
antagonist of smooth muscle contraction has been charac-
terized, its exact role in envenomation remains elusive
especially in MOh which venom contains a considerable
amount of this toxin.
L-amino acid oxidases (LAAOs)
The LAAO transcripts revealed by the MOh venom-gland
transcriptome consist of the three main functional domains
[59] and share high sequence similarity with sequences of
other king cobras (retrieved from the UniprotKB database)
(Fig. 9). The major transcript sequence (MOh_LAO01) in
our study is highly homologous to the sequence of hypo-
thetical protein L345_17374 from the Balinese king cobra
[20] and king cobra OH-LAAO (P81383). Unlike 3FTxs
(that have values of transcript redundancy 10 times higher
than LAAOs), LAAOs appear rather well conserved within
king cobras from different regions.
Snake venom LAAOs are reported present natively as a
homodimer with molecular mass around 120 kDa, while
under reducing conditions, present as subunit of around
50-70 kDa [60]. We showed in our proteomic study that
the LAAOs of MOh venom distributed mainly in gel sec-
tion 3 corresponding to 55-75 kDa (Fig. 3). Despite the
relatively lower mRNA expression, the protein comprises
close to 6 % of MOh venom (Additional file 3), comparable
to the approximation of 8 % w/w in an earlier study of
Malaysian king cobra LAAO [10]. The peptide sequences
exhibit low variability with only two isoforms identified in
the proteome, comparable with the Thai and Balinese sam-
ples where one LAAO subtype was identified [20, 25]. Our
finding is also in agreement with Chang et al. [19] who re-
ported substantial LAAO activity in four king cobra
venoms of different localities, although the paper reported
neither the compositional subtype nor the abundance of
this enzyme. These studies however strongly disagree with
another proteomic study on a Malaysian king cobra sample
where no LAAO was detected at all [24].
The substantial amount of LAAO in the MOh venom
proteome (> 5 %) suggests that the toxin may serve be-
yond ancillary function. Its role in king cobra predation
and envenomation may be related to its potent proin-
flammatory and cytotoxic activity [60] that can induce
extensive tissue destruction. In addition, the functional
uniqueness of king cobra LAAO has been shown on its
substrate specificity compared to other snakes, where its
heat-stable property contributes greatly to its potential
for biomedical application [10]. Notably, LAAO from
the Malaysian king cobra has been shown to exhibit
potent in vitro and in vivo selective cytotoxicity [60, 61].
Further characterizations of king cobra LAAO is there-
fore a feasible and promising research direction towards
cytotoxic drug discovery.
Vespryn (Ohanin)
The complete sequence of the only vespryn transcript in
MOh matches identically to the ohanin sequence (Fig. 10).
The sequence, covering signal and mature chain, is also
identical to the corresponding sequence regions reported
for the Balinese specimen [20] (hypothetical protein
L345_13461). The Balinese king cobra vespryn sequence,
however, contains additional pre-signal 30 amino acid res-
idues (Fig. 10), the significance of which is uncertain. In
contrast to other members of snake venom proteins, oha-
nin presents a unique single cysteine residue (residue 52),
and the protein sequence shares little similarity to the
PRY-SPRY domains (B30.2-like domain) with relatively
short N-terminal extension [62]. Although Thaicobrin
(P82885) isolated from the monocled cobra, Naja
kaouthia was deposited in the protein database much earl-
ier than ohanin, there is no published literature and little
characterization work has been done. Together with Thai-
cobrin, the distinct sequence of ohanin has made them
the first member of vespryns (venom PRY-SPRY domain-
containing proteins) family sourced from snake venom.
Pung et al. [16] reported the presence of ohanin at a low
abundance (~1 mg/g) in king cobra venom sourced from
Jakarta, Indonesia. In contrast, the MOh venom proteomic
study shows the venom contains a higher amount of ohanin
(5.7 %, ~57 mg/g) (Additional file 3) that were distributed
mainly in gel sections 10 and 11 (Fig. 3), corresponding to
the known molecular mass of ohanin (~12 kDa). The differ-
ence in ohanin content in O. hannah venoms from
Malaysia (MOh) and Indonesia (Jakarta) may seem to rep-
resent a remarkable geographical variation of the venoms.
Phospholipases A2 (PLA2s)
The two complete PLA2 transcripts (MOh_PLA01 and
MOh_PLA02) of MOh were annotated to Group IA
(PLA2-2) and IB (PLA2-1), respectively, similar to the
PLA2 enzymes in Chinese O. hannah venoms [15, 63], and
they share the characteristic Asn6 N-terminus for venom
PLA2 of king cobra (Fig. 11). The major PLA2 (4 % of
abundance) expressed in the proteome of MOh venom is
the acidic PLA2-2 (Group IA subtypes), consistent with
Fig. 9 Sequence alignments of L-amino acid oxidase (LAAO) transcripts of Malaysian O. hannah venom-gland transcriptome in comparison with
LAAO sequences of representative venomous snakes. (Black: FAD-binding domain; Red: substrate-binding domain; Blue: helical domain)
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Tan and Saifuddin [14] who reported that the major PLA2
of Malaysian king cobra was an acidic isoform constituting
4 % of the venom weight. The enzyme was however non-
lethal in mice at an intravenous dose of 10 μg/g but exhib-
ited moderate anticoagulant and oedema-inducing (proin-
flammatory) activities, in contrast to the Fujian PLA2-1
(Group IB subtype) that was mildly lethal and cardiotoxic
in mice [63]. Remarkable variations are noted within the
Group I PLA2 among king cobra venoms of different
origin: while we identified Group IA PLA2 from MOh,
Huang et al. [63] isolated only Group IB PLA2 from a
Fujian Chinese sample; Vonk et al. [20] identified two each
for Group IA and Group IB from a Balinese sample; Veja-
yan et al. [24] identified one each of Group IA and Group
IB from a Malaysian sample; Danpaiboon et al. [25] identi-
fied 2 Group IA and 1 Group IB PLA2 from a Thai sample.
With the inconsistency of king cobra PLA2 subtypes identi-
fied, the comparative analysis is further compounded by
undetermined toxin abundance in each study. Chang et al.
[19] showed with quantitation in another Malaysian sample
the presence of 2 Group IA and 1 Group IB PLA2 subtypes,
however each with exceptionally low abundance ranging
from 0.16-0.32 % only, indicating that the total PLA2 con-
tent in the venom was far less than 1 % [19]. The intraspe-
cific PLA2 variations are therefore vast and may be related
to not only geographical distribution but also ontogenic fac-
tors. The current proteomic study, nonetheless, shows that
the MOh major PLA2 is the acidic, proinflammatory but
non-lethal variant of Group IA PLA2. It constitutes a small
portion of the Malaysian king cobra (MOh) venom, ap-
proximately 10 times less than PLA2s found in the regional
Naja cobra venoms (approx. 20-30 %) [34, 40]. In view of
the negligible cytotoxin content and small amount of PLA2,
local tissue necrosis that occurs in MOh envenoming is
possibly induced by other cytotoxic components in the
venom, for instances, SVMPs and LAAOs that exist at a
high abundance.
Cobra venom factors (CVFs)
The trasncripts of cobra venom factors from the MOh
transcriptome are highly homologous to OVF, Ophiopha-
gus venom factor, the CVF first purified from the venom of
a Chinese (Guangxi) king cobra [64]. Interestingly, the OVF
transcripts in MOh transcriptome reveal 9 amino acid
residues (545-553) absent in the reported sequence for
Guangxi OVF, but present identically in that of the Balinese
specimen [20]. This suggests that the structures of OVF
from king cobras of the two Southeast Asian regions share
high similarity and are sufficiently distinct from that of the
China specimen. In addition, two novel regions (residue 3-
42 and 504-544) not reported previously in CVF/OVF have
been identified in the OVF transcript of MOh (Fig. 12).
BLAST analysis of these peptides retrieved no identifiable
protein or peptide region. The role of the additional amino
acid sequences in the structure-function relationship of
Malaysian CVF/OVF remains to be investigated.
The number of CVF subtypes expressed in the MOh
venom (n = 4) is comparable to that reported in the Balinese
specimen (n = 5) [20], but more diverse than the Thai speci-
men and another Malaysian sample [24, 25]. CVF is a pro-
tein with high molecular mass (approx. 150 kDa) and it
dissociates into α, β and γ chains under reducing condition
[64], consistent with our findings where the gel sections 3,
5, 6 and 7 (Fig. 3) corresponded to the reported sizes of α
(72kDa), β (45kDa) and γ chain (32kDa). CVF is not directly
lethal; it facilitates the absorption and spread of venom from
Fig. 10 Sequence alignments of vespryn (ohanin) transcripts of Malayan O. hannah venom-gland transcriptome in comparison with vespryn
sequences of representative venomous snakes. (Blue: additional residues possessed by hypothetical protein L345_13461; Black: three conserved LDP,
WEVE, and LDYE motifs of B30.2-like domains containing protein)
Fig. 11 Sequence alignments of phospholipase A2 (PLA2) transcripts of Malaysian O. hannah venom-gland transcriptome in comparison with
PLA2 sequences of representative venomous snakes. (Red lines: conservative disulfide bonds; Black lines: additional disulfide bond; Blue: 62-67
residues of pancreatic loop)
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the bite site, as CVF-activated local complement system
releases anaphylatoxins C3a and C5a that increase the
regional vascular permeability and blood flow [65].
Low-abundance transcripts and toxins
Toxins constituents expressed in both venom-gland
transcriptome and venom proteome
Kunitz/BPTI serine protease inhibitors (KUNs) transcripts
consitutute 1.84 % of toxin FPKM, while one KUN was
expressed into the venom proteome at 1.0 % of toxin abun-
dance. The expressed KUN protein is similar to OH-TCI,
the first reported KUN from snake venom that exhibited
equivalent trypsin and chymotrypsin inhibitory activities
[17]. In addition, cystatin, an inhibitor of various C1 cyst-
eine proteases that may play a role in preventing toxin
auto-digestion [66], was detected at a low amount in the
transcriptome (0.25 % toxin FPKM) and proteome (0.65 %
toxin abundance). In comparison, the Balinese and Thai
king cobra venoms contain, respectively, 3 and 1 KUN sub-
types but cystatin has not been reported [20, 25]. The exact
function and action of KUNs remain to be elucidated.
From the MOh venom-gland transcriptome, we have
identified 3 transcripts (0.11 % total toxin FPKM) that
encoded neprilysin, a metalloendopeptidase with affinity for
a vast range of physiological targets, including natriuretic
and vasodilatory neuropeptides for their regulation [67].
Novel metallopeptidases exhibiting similarity to neprilysin
was first demonstrated in the venom-gland transcriptomic
study of Echis sp. [68], and recently the neprilysin transcript
was revealed too from the venom gland of the Balinese king
cobra, but its expression in the king cobra venom proteome
was not reported [20]. In this study, we showed that neprily-
sin is present in the venom proteome of Malaysian king
cobra, although its identity and function as a secretory toxin
in the venom are still elusive at this stage of venom study.
From the venom gland transcriptome, three transcripts
were identified for encoding snake venom serine proteases
(SVSPs) at rather low FPKM (0.17 % abundance of total
toxin transcripts). Through LCMS/MS and homology
search, the expressed peptides were noted similar to alpha-
and beta-fibrinogenase OhS1 (0.7 % of venom protein
abundance). In comparison, 3 SVSPs and 1 kallikrein were
identified from the venom proteome of Balinese and Thai
specimens, respectively [20, 25] but not reported in the
other two Malaysian samples [19, 24]. The serine fibrino-
genase in MOh venom has a putative role of a potent fibri-
nogenolytic and amidolytic agent without haemorrhagic
effect [69]. Serine proteases at 5-7 % in viperid venom is
able to elicit significant coagulopathic effect in vivo and in
vitro [70]; this effect however has not been a well-
recognized clinical syndrome in king cobra envenomation,
and laboratory test (APTT) using human plasma for the
venom’s procoagulant effect has not been positive [19]. In
addition to the fibrinogenolytic toxins, phospholipase B
(PLB) with haemolytic activity from Drysdalia coronoides
[71] was detected in a minute amount in the MOh tran-
scriptome and the venom proteome. This enzyme was also
identified in the venom proteome of the Thai specimen
[25] but not reported from the other sources [19, 20, 24].
Acetylcholinesterases (AChEs) are usually expressed at
low level in snake venoms; the highest abundance ever re-
ported was 0.8 % (w/w) from the genus Bungarus (krait)
[72]. The major isoform of AChE transcript from MOh ex-
hibits extremely high homology to AChE full sequence of
Bungarus fasciatus (Q92035), supporting the antigenic
cross-reactivity observed between king cobra AChE and the
monoclonal antibodies of krait AChE [72]. One AChE
(MOh_ACE01) was detected in the MOh venom proteome
at a relatively low abundance (0.1 %). The presence of this
enzyme in king cobra venom was previously identified only
through functional study. Chang et al. [19] showed that the
AChE activities of Malaysian and Thai king cobra venoms
were several-fold higher than the Indonesian and Chinese
samples, and described an inverse relationship between the
AChE activity and the neurotoxic fatality of the venom.
However, the postulation of the ‘inverse relationship’ seems
contradictory as it was suggested that the immediate
acetylcholine hydrolysis at synapses might reduce the com-
petition between the neurotransmitter (acethylcholine) and
the curare-like neurotoxins, thus potentiating the neuro-
toxicity. Besides, although venom AChEs may interrupt
musculatory control through rapid degradation of ACh,
their effect on cholinergic transmission in the central ner-
vous system and autonomic ganglia remains unclear [73].
Systemic hypotension may be a possible effect associated
with the interruption of cholinergic transmission at the
autonomic ganglia, thus favouring prey immobilization.
The transcription of nerve growth factor (NGF) genes in
the MOh venom glands is consistent with the findings for
the Balinese king cobra [20]. A small amount (0.8 %) of
NGF was also detected in the MOh venom proteome. Of
note, the proteomic presence of this minor toxin in king
cobra venoms has not been reported nor quantitated pre-
viously [19, 20, 24, 25]. It has been suggested that NGF
can exhibit arginine esterase activity that contributes to
hypotensive effect through nitric oxide liberation and his-
tamine release [31]. Interestingly, this is a group of snake
venom constituents, after the widely-studied anticoagulant,
Fig. 12 Sequence alignments of cobra venom factor (CVF) transcripts of Malaysian O. hannah venom gland transcriptome in comparison with
CVF sequences of representative venomous snakes. (Black: alpha-chain; Red: gamma-chain; Green: beta-chain; Blue: extra regions)
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antiproliferative and antimicrobial toxins, shown to have
therapeutic potential for neurodegenerative brain disorders,
e.g., Alzheimer’s disease [74, 75].
Phosphodiesterase (PDE) and 5’-nucleotidase were two
other minor toxins detected in both the venom-gland
trasncriptome and venom proteome of MOh. Both the en-
zymes were detected in the venom proteome of Thai king
cobra [25], while only PDE was identified from the Bali-
nese specimen [20]. These enzymes primarily act to liber-
ate nucleosides which may help in prey immobilization
[76–78]. Venom phosphodiesterases are known to cause
locomotor depression and reduction of mean arterial
blood pressure [79]. Together with 5’NUCs and toxins
with hypotensive and immobilising potentials such as
OVF, AChE and NGF, these components may act syner-
gistically to enhance prey subduing.
In comparison with the study on Balinese king cobra
[20], we noticed some variations in the “–omic” findings
between king cobras from the two geographical regions
(Table 1). Besides the variabilities of sequence and abun-
dance described, we also found the inconsistent presence of
a number of toxins between the two specimens. For in-
stance, NGF, AChE, neprilysin, PLB, cystatin and 5’-nucleo-
tidase present in the MOh proteome were not reported in
the Balinese specimen proteome [20]. Conversely, natri-
uretic peptide (NP) and vascular endothelial growth factor
(VEGF) were detected in the venom proteome of the
Balinese specimen [20] but absent in the MOh although
the expression was detected at low mRNA level. One inter-
esting, consistent feature shared by both king cobras from
the Malayan Peninsula and Bali Island is the absence of lec-
tin in the venom proteome in spite of their gene expression
in the venom glands. This observation supports that lectins
do not contribute to king cobra envenoming [20] which is
in contrast to many other venomous snakes particularly
from the Viperidae family [20, 70]. In addition, although
the two specimens did not differ remarkably in the com-
position of major pathogenic toxin components e.g., 3FTxs
and SVMPs, variations are noted in the gene sequences
(Additional file 4) and possibly proteomic abundances (not
reported for the Balinese specimen), indicating intra-
specific venom diversity that may lead to variations in im-
munological profile and antivenom effectiveness.
Toxins not translated from venom-gland transcriptome
Twenty seven toxin transcripts were identified only at the
transcriptional level of MOh venom glands. These tran-
scripts encoded protein genes for insulin growth factors
(IGFs), natriuretic peptides (NPs), hyaluronidase, dipepti-
dylpeptidase IV (DDP-IV), vascular endothelial growth
factors (VEGF), waprins and C-type lectins (CTLs), to-
talled to 1.18 % of all toxin FPKM. The activities of these
toxins have not been previously investigated in king cobra
venom. It is an assumption that their occurence in the
venom is extremely low or negligible since the peptides of
these proteins were not detected by the high resolution
tandem mass spectrometry.
Transcripts of IGFs have been previously categorized into
secretory toxin transcripts by Vonk et al. [20], although its
toxic role is uncertain to date. At the proteomic level, this
toxin was also not reported in both MOh and the Balinese
king cobra venoms, but its presence was detected along
with a hepatocyte growth factor in the Thai specimen
(abundance was not determined) [25]. Natriuretic peptide,
a hormone that controls over natriuresis, diuresis, blood
pressure, homeostasis and inhibition of aldosterone secre-
tion in all vertebrates was not identified in the proteomes
of both MOh and Thai [25] specimen, but reported in the
Balinese specimen proteome [20]. This is another physio-
logical protein which gene was likely recruited earlier into
the toxin arsenal; the expression however has been low
among venomous snakes. Besides, VEGFs, potential vasodi-
lators, were expressed in the venom proteome of the
Balinese specimen [20] but never reported in MOh and the
other king cobra venoms studied [25].
Hyaluronidase, DPP-IV, waprin and CTL were consist-
ently not reported in the venom proteomes of king cobras
(including the Malaysian and Baliense specimens) although
the genes were transcribed in the venom glands [19, 25].
Interestingly, the enzymatic activity of hyaluronidase has
been reported previously in king cobra venom [51] but at a
level much lower than that of Naja sp., Bungarus sp. and
viperid venoms. In this study, a full sequence of hyaluroni-
dase from MOh venom gland transcriptome was identified.
Its high homology to sequences of viperid snakes suggests
that the gene and protein function appear to be conserved
across many venomous lineages despite its trivial expres-
sion in the venom. DPP-IV, waprin and CTL have not been
reported thus far in king cobra venom proteomes; but it re-
mains interesting for further study as complete sequences
of these toxins have been made available from the MOh
venom-gland transcriptome [Additional file 2]. The expres-
sion of these genes without translation into proteins
indicate their early recruitment into the venom-gland tran-
scriptome, however, adaptation and selection have favored
the expression of other toxins to suit the predatory arm-
race and ecological niche changes for the king cobras. An
alternative possible explanation for this is the convergence
of some genes which begin to emerge as potential contribu-
tor of toxins in adaptation to the changing niche. Data of
these sequences may serve useful purposes for biodiversity
study and drug discovery in the future.
Conclusion
This study demonstrates complex and diverse compos-
ition of Malaysian king cobra venom at both the transcrip-
tomic and proteomic levels. Unlike venoms of Southeast
Asian Naja sp. that mainly comprise neurotoxins, PLA2s
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and cytotoxins, MOh venom contains a higher degree of
toxin complexity predominated with neurotoxins and
SVMPs, in addition to appreciable amounts of CRISP,
LAAO, CVFs, vespryn, PLA2 and NGF. Additionally, the
MOh venom contains small amounts of neprilysins and
AChE which may have synergistic action on the neurotox-
icity of the venom. The findings also suggest the presence
of toxins that may induce hypolocomotive and hypotensive
effects in the venom, although clinically humans are sus-
ceptible more rapidly to neuromuscular paralysis due to the
faster absorption of neurotoxins and their intrinsic toxicity
with a rapid onset [80]. The unique toxin composition of
king cobra venom may serve to aid this ophiophagic spe-
cies in preying on other snakes especially Naja cobras
which are known to be neurotoxin-resistant [35].
As anticipated, intra-species variation of venom is not
uncommon, and this is exemplified by the king cobras
among the peninsular Malaysian (MOh), the Thai and
the insular Balinese specimens. We propose the need to
address the medical concerns of such phenomenon,
where comparative studies in the future should aim to
provide variation details in terms of the sequence diver-
sification and the relative abundance of toxins between
venoms of different geographical sources. The integrated
transcriptomic-proteomic knowledge as such is funda-
mental for deeper insights into the mechanisms of snake
venom toxicity and the natural history of venom evolu-
tion. The knowledge may provide crucial information for
optimizing the production of an effective pan-regional
antivenom for related species in the future.
Methods
Snake venom gland preparation
The specimen was an adult Ophiophagus hannah measur-
ing 190 cm in total length captured in a suburban vicinity
of Seremban (central Peninsular Malaya), and identified by
the authors CHT and NHT. Venom was milked from the
live specimen by inducing the snake to bite through a clean
plastic film stretched over a strile container, while gentle
massage was applied to both glands for 20 sec to ensure
maximum venom collection. The venom was lyophilized
and stored at -20 °C until used. Venom milking was carried
out to stimulate the venom gland transcription, while the
snake was allowed to rest for four days for the transcription
process to be maximized [81]. Following euthanasia, the
venom glands were swiftly removed and sectioned into di-
mensions of < 5x5 mm before preserving them in RNAlater
solution at a 1:10 volume ratio. The solution was allowed to
permeate the tissues at 4 °C overnight before transferring
to -80 °C for storage until further use. The use of snake has
been granted by the Department of Wildlife and National
Parks, Peninsular Malaysia (#JPHL&TN (lP): 80-4/2), and
the procedure was approved as of the protocol for snake
venom milking and tissue use for research (#2013-11-12/
PHAR/R/TCH) by the Institutional Animal Use and Care
Committee (IACUC) of the University of Malaya, Malaysia.
Total RNA extraction and mRNA purification
The dissected venom gland tissue was submerged and ho-
mogenized in a 1 mL glass homogeniser with TRIzol solu-
tion (Invitrogen) under sterile condition. This was followed
by the addition of 20 % chloroform, centrifugation and
RNA-free DNAase I treatment to separate RNA from cellu-
lar debris and residual DNA. The isolated RNA was then
pelleted with isopropyl alcohol and washed with 75 % etha-
nol. Polyadenylated mRNA (poly(A)+ RNA) was subse-
quently purified from 20 mg of total RNA using oligo(dT)
magnetic beads as per the Illumina manufacturer’s in-
structions. Two rounds of poly-A+ mRNA isolation were
performed.
DNA library construction and sequencing
Enriched poly(A)+ mRNA isolated from the total venom-
gland RNA was used for cDNA construction. The mRNA
isolated was fragmented in standard buffer containing diva-
lent cations (Zn2+) into short fragments, which acted as
templates for cDNA synthesis. Random hexamer-primer
(N6) was used to synthesize the first-strand cDNA, followed
by second-strand cDNA synthesis with the double-stranded
cDNA as input material, using second strand buffer,
dNTPs, RNase H and DNA polymerase I. From these
cDNA, a paired-end library was synthesized using the Gen-
omic Sample Prep kit (Illumina), according to the manufac-
turer’s instructions. Short fragments were purified with
QIAquick PCR extraction kit (Qiagen) and resolved with
EB buffer for end repair and the addition of poly(A) by the
use of Klenow fragment to aid in the subsequent ligation of
the Illumina adaptors, which contain a single thymine (T)
base overhang at their 3’ ends. Following the ligation with
sequencing adaptors, these short fragments of cDNA were
PCR-amplified and electrophorezed on a 1.5 % to 2 % TAE
agarose gel. From the electrophoretic agarose gel, suitable
fragments (200nt-700nt) were selected as templates for
subsequent PCR amplification. Sequencing of the PCR-
amplified library was then accomplished in a single lane on
the Illumina HiSeq™ 2000 platform with 100-base-pair,
paired-end reads.
Raw sequence data and filtering
Sequenced data from Illumina HiSeq™ 2000 were trans-
formed by base calling into sequence data, called the
raw data or raw reads and were stored in fastq format.
Raw reads were filtered by removing (i) adaptors; (ii)
reads with > 5 % of unknown nucleotides, or (iii) low
quality reads with > 20 % of low quality bases (deter-
mined as base quality ≤ 10), hence yielding clean data or
clean reads.
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De novo transcriptome assembly
De novo ‘shot-gun’ transcriptome assembly was carried
out with the short reads assembling programme, Trinity
[26]. Three independent software modules i.e., Inchworm,
Chrysalis, and Butterfly, comprised the Trinity programme
and were sequentially applied to process the large volumes
of RNA-seq reads. In brief, this was based on the algorithm
of de Bruijn graph construction which began by aligning k-
mers (k = 25), and reads with certain length of overlap were
joined to form linear contigs. The reads were mapped back
onto contigs, and by referring to paired-end reads, contigs
from the same transcript as well as the distances between
them were determined. The contigs were then partitioned
into clusters, each of which carried a complete set of de
Bruijn graphs (representing the transcriptional complexity
at a given gene or locus). The graphs were independently
processed to obtain full-length transcripts for alternatively
spliced isoforms, and to tease apart transcripts that corre-
sponded to paralogous genes.
Transcript clustering
The transcript sequences generated through Trinity were
called Unigenes. Unigenes from the transcriptome assembly
were further processed for sequence splicing and redun-
dancy removing with TGI Clustering tools (TGICL) to ac-
quire non-redundant transcripts at the longest possible
length. The transcripts were then subjected to family clus-
tering, which resulted in two classes of transcripts: (a) Clus-
ters, with a prefix CL and the cluster id behind; (b)
Singletons, which id was simply left with a prefix of Uni-
gene. In each Cluster, there are several transcripts which se-
quence similarities among them being > 70 %; while the
singletons ‘Unigenes’ lack overlapping with other fragments
at the given stringency.
In the following step, the transcript Unigenes were aligned
by BLASTX to protein databases in the priority order of
NCBI non-redundant (NR), Swiss-Prot, KEGG and COG,
with a cut-off E value < 10−5. Proteins with the highest
ranks in the BLASTX results were referred to determine
the coding region sequences of the Unigenes, followed by
translation into amino acid sequences (using the standard
codon table). Hence, both the nucleotide sequences (5' -
3') and amino sequences of the Unigene-coding regions
were acquired. Transcript Unigenes unaligned to any of
the protein databases were analyzed by a software named
ESTScan [82] to determine the nucleotide sequence (5’-3’)
direction and amino sequence of the predicted coding
region. The length of sequences assembled was a criterion
for assembly success. The distributions of the lengths of
contigs, scaffolds, and Unigenes were calculated.
Functional annotation of the transcripts
The process retrieved proteins with the highest sequence
similarity with the given transcript along with their
protein functional annotations, recorded in the Annota-
tion Folder. Annotation of the transcripts provides infor-
mation of the mRNA expressions (see below) and the
putative protein functions. For functional annotation, the
generated transcript sequences were firstly aligned by
BLASTX to certain protein databases e.g., NR, Swiss-Prot,
KEGG and COG (each with a cut-off E-value < 10−5), and
aligned by BLASTN to nucleotide databases NT (cut-off
E-value < 10−5).
Expression annotation of the transcripts
To determine the transcript abundances for the identi-
fied genes, the FPKM method (Fragments Per Kilobase
of exon model per Million mapped reads) [38] was used.
The formula is shown below:
FPKM of gene A ¼ 10
6 C
N L=103
where FPKM is set to be the expression of gene A, C to
the number of fragments (i.e., reads) that uniquely
aligned to gene A, N to be the total number of frag-
ments (i.e., reads) that uniquely aligned to all genes, and
L to be the base number in the CDS of gene A. The
FPKM method is able to eliminate the influence of dif-
ferent gene length and sequencing discrepancy on the
calculation of gene expression.
Venom-gland transcript classification based on toxinology
Data in the Annotation folder (from BLAST analyses) were
further studied to determine which transcripts (Unigenes)
could be identified as toxin, or non-toxin categories. Key-
words were used in search-and-find of the subject descrip-
tion for each toxin match. In view that the final translated
toxin products are proteins in nature, the encoded amino
acid sequences of each transcript sharing a same keyword
description were manually checked for their sequence
similarity using Mutalin® software [83], and subjected to
BLASTp (protein suite) search to ascertain homology with
known toxins. Transcripts for cellular proteins and house-
keeping genes were categorized into “non-toxins” while
those without significant hits/matches were classified as
‘unidentified’. The relative expression of BLAST-annotated
venom-gland transcriptomic Unigenes (in % of the three
categories), the relative abundance and the diversity of
various toxins in % of (i) total protein-encoding transcripts,
and (ii) total toxin-encoding transcripts were determined.
Redundancy of gene families
In addition, the redundancy of gene was assessed by div-
iding the transcriptional activity level or transcript reads
(FPKM) with the total number of transcripts within a
cluster or a group of genes. High redundancy indicates
high expression level of a gene group.
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1D SDS PAGE and in-gel trypsin digestion
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was
conducted according to the method of Laemmli [84] cali-
brated with the Thermo Scientific PageRuler Prestained
Protein Ladder (10 - 170 kDa). The Malaysian O. hannah
(MOh) venom (100 μg) was loaded onto a 15 % gel and the
electrophoresis was performed under reducing condition at
80 V for 2.5 h. Proteins were stained with Coomassie
Brilliant Blue R-250 and a total of 12 gel sections were cut
across the sample lane. Each gel section was further excised
into smaller pieces (~1 × 2 mm) and stored in a 600 μL
micro-centrifuge tube. In-gel digestion was performed
using in-gel tryptic digestion kit from Thermo Scientific.
The gel pieces were destained for 30 min at 37 °C with
shaking, and the in-gel proteins were then reduced at 60 °C
for 10 min with reducing buffer and alkylated in the dark at
room temperature for 1 h. Washing was repeated with
destaining buffer at 37 °C for 15 min followed by dehydra-
tion using 50 % acetonitrile for 15 min. Gel pieces were
allowed to air-dry for 5-10 min, and subsequently incu-
bated with activated trypsin solution at room temperature
for 15 min. Digestion buffer were added to the tube and
incubate sample at 30 °C overnight with shaking. The
digested mixtures were then separated, and further extrac-
tion of peptides was archieved by incubated 1 % trifluoroa-
cetic acid solution with the gel pieces for 5 min. The
digested protein samples were desalted and concentrated
with a C18 ZipTip (Millipore).
Nano ESI-liquid chromatography and tandem mass
spectrometry (nano-ESI-LCMS/MS)
The digested peptide eluates were subjected to nano-
electrospray ionization (ESI) MS/MS experiments using
an Agilent 1200 HPLC-Chip/MS Interface, coupled with
Agilent 6520 Accurate-Mass Q-TOF LC/MS system. Sam-
ples were loaded in a large capacity chip 300 Å, C18, 160
nL enrichment column and 75 μm× 150 mm analytical
column (Agilent part N° G4240-62010) with a flow rate of
4 μl/min from a capillary pump and 0.3 μl/min from a
Nano pump of Agilent 1200 series. Injection volume was
adjusted to 1 μl per sample and the mobile phases were
0.1 % formic acid in water (A) and 90 % acetonitrile in
water with 0.1 % formic acid (B). A gradient of 47 min (3–
50 % solution B for 30 min, 50–95 % solution B for 2 min,
and 95 % solution B for 5 min) was applied using Agilent
1200 series nano-flow LC pump. Ion polarity was set to
positive ionization mode. Drying gas flow rate was 5 L/
min and drying gas temperature was 325 °C. Fragmentor
voltage was 175 V and the capillary voltage was set to
1995 V. Spectra were acquired in a MS/MS mode with a
MS scan range of 110–3000 m/z and MS/MS scan range
of 50–3000 m/z. Precursor charge selection was set as
doubly, triply or up to triply charged state with the
exclusion of precursors 922.0098 m/z (z = 1) and 121.0509
(z = 1) set as reference ions. Data was extracted with MH+
mass range between 600-4000 Da and processed with
Agilent Spectrum Mill MS Proteomics Workbench
software packages. Carbamidomethylation of cysteine was
set as a single modification. The peptide finger mapping
was modified to specifically search against a merged data-
base consisting of all non-redundant NCBI database with
taxonomy set to Serpentes (taxid: 8570), and private data-
base generated from the venom-gland transcriptome of
the particular snake used in this study. Protein identifica-
tions were validated with the following filters: protein
score >11, peptides score >6 and scored peak intensity
(SPI) >60 %. Only results with “Distinct Peptide” identifi-
cation of 2 or greater than 2 are considered significant.
Gel intensity estimation and label-free LCMS/MS protein
quantitation
The abundance of a protein within a gel section was deter-
mined based on the mean spectral intensity (MSI) relative
to the total mean spectral intensity of all proteins from
the gel section. Label-free LCMS/MS relative quantitation
methods have been recently applied in many studies in-
cluding venom shotgun proteomics [31]. To compensate
for potential discrepancy between gel sections due to
manual handling on gel excision and in-gel digestion, the
relative MSI of a protein was adjusted according to the
relative intensity of the corresponding gel section (deter-
mined with Thermo Scientific Pierce myImage Analysis
Software). The generic equation is summarized below:
Relative abundance of protien A in gel section 1
¼ Mean spectral intensity of protien A in Section 1
Total mean spectral intensity in Section 1
 
x Relative gel intensity of Section 1 %ð Þ
The total abundance of a protein throughout the SDS-
PAGE lane is the sum of its relative abundances from all
gel sections.
Correlation of mRNA expression and protein abundance
The method was modified from Aird et al. [31]; essentially
the protein expression was measured based on peptide
unit, analogous to the analysis for RNA expression de-
scribed by [38]. In our study, for each protein identified in
every gel section, the expression of its peptide fragment
was first determined by dividing the number of its frag-
ments with the number of total fragments in the gel sec-
tion. The ratio is then multiplied with the corresponding
gel section intensity (% by densitometry) to obtain the
normalized measure of its peptide fragment per section
(PFPS). The PFPS was then further divided by the length
of the protein in order to normalize for size across various
proteins, hence producing a measure of peptides per unit
length (PPUL) of protein as described by Aird et al. [31].
The following is the calculation for the PPUL of a protein:
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Subsequently, the PPUL and FPKM values and the re-
dundancies were cumulated according to protein family.
Correlations were estimated by using parametric (Pearson’s
product–moment correlation coefficients) statistics.
Sequence alignment and phylogeny tree construction
Amino acid sequences form relevant comparative venom
toxins were retrieved from the UniProtKB database (http://
www.uniprot.org/). Multiple sequence alignment was per-
formed with MUSCLE program [85] using Jalview software
[86] and phylogenetic tree was constructed with Mega 6
[87] using the Maximum Likelihood method. FigTree 1.4
was used to produce phylogenetic tree figures. Neurotoxin-
1 (P01479) of the Saharan scorpion Androctonus australis
was used as outgroup.
Availability of supporting data
Sequence data from the venom-gland transcriptome of the
Malaysian king cobra, Ophiophagus hannah has been de-
posited in National Center for Biotechnology Information
(NCBI) Sequence Read Archive (http://www.ncbi.nlm.nih.
gov/Traces/sra/sra.cgi) under bioproject: PRJNA276622
(accession number SRP055563) (http://www.ncbi.nlm.nih.
gov/sra/SRP055563).
The primary data (multiple sequence alignments and
phylogenetic tree) and other additional files of data ana-




Additional file 1: Malaysian Ophiophagus hannah venom-gland
transcriptome (Transcript FPKM >1). (XLSX 13641 kb)
Additional file 2: Malaysian Ophiophagus hannah Venom-gland
Transcriptome Toxins Annotations. (XLSX 147 kb)
Additional file 3: Malaysian Ophiophagus hannah venom proteome.
(XLSX 223 kb)
Additional file 4: Sequence comparision of Malaysian Ophiophagus
hannah (MOh; current study) with Balinese species (BOh; Vonk et al.
[20]) and other reported O. hannah toxins deposited in public
database. First column indicates the sources of the sequence used in
the comparison. Second column indicates the protein family and ID of
the current study and NCBI deposited public database (Abbrev.: 3FTx,
three-finger toxin; SVMP, snake venom metalloproteinase; PLA2, phospho-
lipase A2; CRISP, cysteine-rich secretory protein; KUN, Kunitz-type protein-
ase inhibitor; LAAO, L-amino acid oxidase; CVF, Cobra venom factor; IGF,
insulin-like growth factor; NP, natriuretic peptide; SVSP, snake venom
serine protease; PDE, phosphodiesterase; NGF, nerve growth factor; AChE,
acetylcholinesterase; PLB, phospholipase-B; DPP IV, dipeptidylpeptidase IV;
CTL, C-type lectin; VEGF, vascular endothelial growth factor). Third column
shows the accession number of NCBI and SwissProt database on the first
row and (where present) the number of the line in which the peptide
match is found in the protein in the subsequent rows. Forth column shows
the comparison of MOh with BOh (Vonk et al. [20]) and other reported O.
hannah toxins using the sequences retrieved from MOh transcriptome
(current study) and NCBI database. Fifth column shows the coverage of the
MOh sequences as compared to the aligned sequences. Underline indicates
signal peptide sequences; green indicates peptide matches; red indicates
the amino acids diverse from the aligned sequences; purple indicated
sequences neither matched to O. hannah species nor BOh toxins. *Sequence
comparision were based on the annotated protein ID in Addtional file 2; two
filters were made for the selections: 1) every protein ID annotated to O.
hannah species; 2) proteins of other snake species which are also reported
in Vonk et al. [20], i.e., neurotoxin-like protein 1, belonged to [Causus
rhombeatus] species but reported in BOh species. (XLSX 31 kb)
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